Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-05-08
2007-05-08
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S133000, C514S305000
Reexamination Certificate
active
11325787
ABSTRACT:
Compounds of formula I:wherein A, D, Ar1, E and Ar2are as defined in the specification, processes for preparing them, pharmaceutical compositions containing them and their use in therapy, especially in the treatment or prophylaxis of psychotic and intellectual impairment disorders.
REFERENCES:
patent: 4657911 (1987-04-01), Imbert et al.
patent: 6492385 (2002-12-01), Myers et al.
patent: 0190920 (1986-08-01), None
patent: 0327335 (1989-08-01), None
patent: 0546181 (1993-06-01), None
patent: 1219622 (2002-07-01), None
patent: 1416872 (1975-12-01), None
patent: WO01/36417 (2001-05-01), None
patent: WO 0192259 (2001-12-01), None
patent: WO 0192260 (2001-12-01), None
patent: WO 0192261 (2001-12-01), None
patent: WO 0198253 (2001-12-01), None
patent: WO 0215662 (2002-02-01), None
patent: WO 0216355 (2002-02-01), None
patent: WO 0216356 (2002-02-01), None
patent: WO 0216357 (2002-02-01), None
patent: WO 0216358 (2002-02-01), None
patent: WO 02177358 (2002-02-01), None
patent: WO 0220521 (2002-03-01), None
patent: WO 0136417 (2002-05-01), None
patent: WO 0244176 (2002-06-01), None
STN International, Caplus accession No. 1993:213064, document No. 118:213064, Takeda Chem Industries, Ltd: Preparation of five-membered heterocyclic amide derivatives, JP, A2; 04247081, Sep. 3, 1992.
STN International, Caplus accession No. 1996:383036, document No. 125: 167754, Brown, George R. et al: Synthesis and Activity of a Novel Series of 3-Biarylquinuclidine Squalene Synthase Inhibitors, J. Med. Chem (1996), 39(15), 2971-2979.
“Reach-Through Claims,” internet article published Apr. 2, 2002, Baker Botts, LLP; http://bakerbotts.com
ews/inprint/reachthroughclaims.
Phillips Eifion
Schmiesing Richard
AstraZeneca AB
Coppins Janet L
Mitchell Kenneth F.
Saeed Kamal A.
LandOfFree
Compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3774462